Key Record Dates
ClinicalTrials.gov Identifier: | NCT05573126 |
---|---|
Brief Title: | Phase 1/2 Study to Evaluate EP0062 in Patients With Relapsed Locally Advanced or Metastatic Androgen Receptor Positive (AR+)/HER2-/ER+ Breast Cancer |
First Submitted : | October 3, 2022 |
First Submitted that Met QC Criteria : | October 5, 2022 |
First Posted : | October 10, 2022 |
Last Update Submitted that Met QC Criteria : | October 5, 2022 |
Last Update Posted : | October 10, 2022 |